Project Search Results

Select

Research Categorization

Operator
Operator

Project Details

Operator
Operator

Contact Researcher and Awardee Organization

Operator
Operator

Funding Organization

Operator
Operator
Operator
Operator
Displaying 1 - 10 of 11 Clinical Trials
ID/Name Source Type
A Study to Evaluate the Efficacy and Safety of ABBV-8E12 in Subjects With Early Alzheimer's Disease
NCT02880956 clinicaltrials.gov Clinical Trial
Efficacy and Safety Study for Subjects With Mild-to-Moderate Alzheimer's Disease
NCT00948909 clinicaltrials.gov Clinical Trial
Efficacy and Safety Study of ABT-288 in Subjects With Mild-to-Moderate Alzheimer's Disease
NCT01018875 clinicaltrials.gov Clinical Trial
Efficacy and Safety Study of ABT-384 in Subjects With Mild-to-Moderate Alzheimer's Disease
NCT01137526 clinicaltrials.gov Clinical Trial
Evaluate the Efficacy and Safety of ABT-126 in Subjects With Mild to Moderate Alzheimer's Disease
NCT01527916 clinicaltrials.gov Clinical Trial
Evaluate the Efficacy and Safety of ABT-126 in Subjects With Mild to Moderate Alzheimer's Disease on Stable Doses of Acetylcholinesterase Inhibitors
NCT01549834 clinicaltrials.gov Clinical Trial
Evaluation of the Diagnostic Potential of BAY1006578 in Probable Alzheimers Disease Patients Versus Healthy Volunteers and Radiation Dosimetry of BAY1006578 in Healthy Volunteers
NCT01153607 clinicaltrials.gov Clinical Trial
Florbetaben (BAY94-9172) PET (Positron Emission Tomography) Imaging in MCI (Mild Cognitive Impairment) Patients
NCT01138111 clinicaltrials.gov Clinical Trial
Phase II Study of Florbetaben (BAY 94-9172) PET Imaging for Detection/Exclusion of Cerebral β-amyloid in Patients With Probable Alzheimer's Disease Compared to Healthy Volunteers
NCT00750282 clinicaltrials.gov Clinical Trial
Phase III Study of Florbetaben (BAY94-9172) PET Imaging for Detection/Exclusion of Cerebral β-amyloid Compared to Histopathology
NCT01020838 clinicaltrials.gov Clinical Trial